Your browser doesn't support javascript.
loading
Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition.
Wei, Xi; Li, Qing; Li, Ying; Duan, Wei; Huang, Chongbiao; Zheng, Xiangqian; Sun, Lei; Luo, Jingtao; Wang, Dong; Zhang, Sheng; Xin, Xiaojie; Gao, Ming.
Afiliación
  • Wei X; Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Li Q; These authors contributed equally to this work.
  • Li Y; Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.
  • Duan W; These authors contributed equally to this work.
  • Huang C; The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Zheng X; These authors contributed equally to this work.
  • Sun L; Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.
  • Luo J; Department of Senior Ward, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Wang D; Department of Thyroid and Cervical Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Zhang S; Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Xin X; The Department of Otorhinolaryngology and Maxillofacial Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute, National Clinical Research Center of Cancer, Tianjin, China.
  • Gao M; Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.
Oncotarget ; 13: 118-119, 2022.
Article en En | MEDLINE | ID: mdl-35035777
ABSTRACT
[This corrects the article DOI 10.18632/oncotarget.8660.].
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2022 Tipo del documento: Article País de afiliación: China